NEW YORK (GenomeWeb News) – Genomatix Software said today that Pfizer has licensed use of its software and databases for use by Pfizer Pharmaceuticals’ sites around the world.
 
The Munich, Germany-based bioinformatics company said that Pfizer will use the software and data content “to help understand the molecular basis of how their potential drug targets may be co-regulated with other important targets, producing potential desirable or unwanted side effects.”
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.